HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Ciarleglio Selected Research

ganglio-N-triaosylceramide

11/2007Increased lung surfactant phosphatidylcholine in patients affected by lysosomal storage diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Ciarleglio Research Topics

Disease

1Sarcoidosis (Schaumann Disease)
09/2008
1Neuraminidase 1 deficiency
11/2007
1Gaucher Disease (Gaucher's Disease)
11/2007
1Mucolipidoses (Sialidosis)
11/2007
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2007
1Sandhoff Disease (Sandhoff's Disease)
11/2007
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/2007

Drug/Important Bio-Agent (IBA)

1Carbon MonoxideIBA
09/2008
1beta-N-AcetylhexosaminidasesIBA
11/2007
1Glucosylceramidase (Glucocerebrosidase)IBA
11/2007
1Glucosylceramides (Glucocerebrosides)IBA
11/2007
1Neuraminidase (Sialidase)IBA
11/2007
1OligosaccharidesIBA
11/2007
1Phosphatidylcholines (Phosphatidylcholine)IBA
11/2007
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2007
1Surface-Active Agents (Surfactants)IBA
11/2007
1ganglio-N-triaosylceramideIBA
11/2007
1phosphatidylethanolamineIBA
11/2007